CLINICAL_TRIALS
trial_result
· 2021-12-08
Clinical Trial Update: An Open Label Extension Study of the Efficacy of MORAb-003 [Phase 2]
Summary
Open-label extension study of MORAb-003 (epithelial ovarian cancer) in Phase 2 has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphotek | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-12-08